Banco Santander SA (SAN)

5.51
0.11 2.04
NYSE : Financial
Prev Close 5.40
Open 5.47
Day Low/High 5.46 / 5.53
52 Wk Low/High 3.60 / 5.45
Volume 3.96M
Avg Volume 5.36M
Exchange NYSE
Shares Outstanding 14.43B
Market Cap 78.38B
EPS 0.40
Div & Yield 0.23 (4.30%)

Latest News

A Seismic Shift in Stock Picking: Cramer's 'Mad Money' Recap (Thursday 1/12/17)

A Seismic Shift in Stock Picking: Cramer's 'Mad Money' Recap (Thursday 1/12/17)

Amazon.com has all the qualities we really want from our stocks - now, says Jim Cramer.

(Graphic: Business Wire)

(Graphic: Business Wire)

Sanofi and Boehringer Ingelheim confirmed today that the strategic transaction signed in June 2016, which consists of an exchange of Sanofi's animal health business (Merial) and Boehringer Ingelheim's consumer...

Santander Donates More Than $3.3 Million In New Charitable Giving To 118 Non-Profit Organizations

Santander Donates More Than $3.3 Million In New Charitable Giving To 118 Non-Profit Organizations

New Grants Bring Santander's Total Community-Based Donations in 2016 to Nearly $10 Million

Drugs Were a Downer in 2016 and Could Be Again in 2017: Exane BNP

Drugs Were a Downer in 2016 and Could Be Again in 2017: Exane BNP

The key trends for 2016 were falling insulin prices, falling returns on R&D and lower approval rates, according to analysts at the French bank.

Sanofi Genzyme Announces Start Of Phase III Study Of Isatuximab For Relapsed And Refractory Multiple Myeloma

Sanofi Genzyme Announces Start Of Phase III Study Of Isatuximab For Relapsed And Refractory Multiple Myeloma

Sanofi Genzyme, the specialty care global business unit of Sanofi, today announced the initiation of the ICARIA-MM Phase III trial of isatuximab, an investigational anti-CD38 monoclonal antibody being studied for the...

RBS Pledges Further Balance Sheet Action Following Stress Test Failure

RBS Pledges Further Balance Sheet Action Following Stress Test Failure

Royal Bank of Scotland's stress-test failure marks another twist in a long and winding road to recovery for the beleaguered lender.

RBS Fails Bank of England Stress Tests, Pledges New Capital Plan

RBS Fails Bank of England Stress Tests, Pledges New Capital Plan

RBS misses both key targets in Bank of England tests, says it must "do more" to restore resilience.

Banco Santander Stock Rises on Shareholder Payout Bets After ECB Capital Report

Banco Santander Stock Rises on Shareholder Payout Bets After ECB Capital Report

A less stringent ECB capital target has investors betting on a bigger payout for shareholders.

New Survey Finds Men In The U.S. Want To Take Charge Of Their Own Health And Wellness

New Survey Finds Men In The U.S. Want To Take Charge Of Their Own Health And Wellness

Data also Shows Men Consider Sexual Health to be an Important Priority

There's Still Time to Buy These 5 Big-Cap Breakouts

There's Still Time to Buy These 5 Big-Cap Breakouts

Here's a technical look at how to trade some of the biggest stocks on Wall Street, including Texas Instruments, Schlumberger and Exxon Mobil.

Poste Italiane Courts UniCredit's $3.2 Billion Pioneer Asset Manager

Poste Italiane Courts UniCredit's $3.2 Billion Pioneer Asset Manager

The postal services operator will merge its fund management unit with bid partner Anima to bulk up for the offer.

European Bank Stocks Fall as Trump Win Highlights Business Risks

European Bank Stocks Fall as Trump Win Highlights Business Risks

The prospect of a trade spat with China puts HSBC in the spotlight as Deutsche Bank wilts on regulation worries.

BBVA & Banco Santander: Two of Europe's Biggest Losers From Trump's Presidency

BBVA & Banco Santander: Two of Europe's Biggest Losers From Trump's Presidency

Significant exposures to Mexico, as well as European economies, leave both bank stocks reeling.

Sanofi Genzyme Begins Pivotal Phase 3 Trial Of NeoGAA Investigational Second-Generation Therapy For Pompe Disease

Sanofi Genzyme Begins Pivotal Phase 3 Trial Of NeoGAA Investigational Second-Generation Therapy For Pompe Disease

Sanofi Genzyme, the specialty care global business unit of Sanofi, announced today that the first patient has been enrolled and received an infusion in a pivotal Phase 3 clinical trial named COMET for the...

Santander's Business Banking Customers Are Going Mobile

Santander's Business Banking Customers Are Going Mobile

Bank Launches Self-Service Mobile App Exclusively for Business Customers; Adds New Functionality to its Consumer App to Improve the Customer Experience

RBS Warns of Another EC Deadline Miss as It Beats Profit Forecasts

RBS Warns of Another EC Deadline Miss as It Beats Profit Forecasts

Shares in the lender rise more than 4% in early trading.

European Stocks Slide As Oil Falls Back and Earnings Disappoint

European Stocks Slide As Oil Falls Back and Earnings Disappoint

U.K. lender Lloyds falls after a third-quarter profit miss, while luxury goods maker Kering surges.

Provisions, Restructuring News Top RBS Investors' Quarterly Wish List

Shareholders will also strain for information on the post-Brexit outlook at the Edinburgh lender.

European Week Ahead: GDP Data, Consumer Poll to Measure Brexit Damage

European Week Ahead: GDP Data, Consumer Poll to Measure Brexit Damage

Forward-looking purchasing managers' indices and earnings from beleaguered lender Deutsche Bank feature among the other release highlights.

UniCredit Shifts $1 Billion Bad Loan Portfolio Amid Italian Banking Shakeup

UniCredit Shifts $1 Billion Bad Loan Portfolio Amid Italian Banking Shakeup

The sale of a bad loan portfolio to Poland's Kruk follows projections of a pick-up in transactions in the second half of the year.